NyquistAI
NyquistAI is a Palo Alto-based SaaS company that applies AI fine-tuned on 1B+ life sciences data points to regulatory intelligence, clinical trial analysis, and systematic literature reviews for pharma, medtech, consulting, and academic customers worldwide.
- Company typePrivate
- Founded2020
- HeadquartersPalo Alto, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What NyquistAI does
NyquistAI (legal entity: Nyquist Data, Inc., Delaware) is a Palo Alto-based AI software company that builds a life sciences intelligence platform aggregating over 1 billion data points across 770K+ clinical trials, 2.5M+ approved devices, 700K+ approved drugs, and 25M+ adverse events in six major markets (US, Australia, Canada, Japan, EU, China). Its proprietary AI is fine-tuned on this corpus to deliver context-aware search, synthesis, and analysis for regulatory and clinical workflows that previously required manual effort — for example, compressing a 2.5-day FDA MAUDE analysis to 40 minutes for a regulatory consulting client.
The company productizes its data and AI layer across six distinct offerings: Nyquist Pharma (global clinical pipeline and on-market therapy data), Nyquist MedTech (medical device, predicate mapping, adverse event, and global registration data), Nyquist IQ (a generative AI research assistant for internal document libraries), Nyquist Scholar (a systematic literature review platform claiming 40–60% screening-time reduction), Guidance IQ (FDA and EU guidance Q&A), and Custom Solutions (bespoke AI builds for internal document management and form-filling). In 2025–2026, NyquistAI extended its distribution through an MCP Server compatible with ChatGPT and Claude and a listing in the ChatGPT App Directory, positioning its regulatory data as a native layer within third-party AI assistants.
The business operates a per-seat SaaS model with published pricing ranging from $49/month (Nyquist IQ) to $459/month (All Access), with a 20% discount for annual commitments, alongside custom enterprise pricing for bundle deals and bespoke builds. NyquistAI serves over 200 global customers including Medtronic, Bayer, Align Technology, HOYA, Cook Medical, Astellas, Viz.ai, and BCG in pharma, medtech, consulting, and academic segments (Harvard, Stanford, UCLA, University of Tokyo). The company is venture-backed, with a disclosed $6M round in March 2022 led by Peterson Ventures alongside Lightspeed Venture Partners, GSR Ventures, Mentors Fund, and TA Ventures, plus undisclosed participation from Village Global, Worm Capital, Catchlight Capital Partners, Liquid 2 Ventures, and ICLUB VC.
NyquistAI firmographics
Firmographics- Name
- NyquistAI
- Legal name
- Nyquist Data, Inc.
- Website
- https://nyquistai.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NyquistAI is a Palo Alto-based SaaS company that applies AI fine-tuned on 1B+ life sciences data points to regulatory intelligence, clinical trial analysis, and systematic literature reviews for pharma, medtech, consulting, and academic customers worldwide.
- Ownership category
- akta.pro rank
NyquistAI industry classification
Industry- Product category
- Life Sciences Regulatory Intelligence Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
Keywords
Where NyquistAI is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NyquistAI business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- Subscription SaaS - Global Intelligence Plans: Recurring monthly or annual subscription model for access to Nyquist Pharma, Nyquist MedTech, and All Access (combined) data platforms. Billed per seat with discounts for annual payment (20% savings). Includes features like Alerts, News Feed, Doc Collaboration, and GuidanceIQ.
- Subscription SaaS - Nyquist Scholar: Per-seat subscription for the systematic literature review platform. Includes comprehensive data access, paper management, streamlined screening, predictive screening AI, extraction & reporting, and AI-powered assistance.
- Subscription SaaS - Nyquist IQ: Private and secure research ally subscription offering fine-tuned Life Science AI for swift insights from selected content. Includes 10x faster insights, curated AI training set, instant query results, and transparent references.
- Custom Solutions: Custom AI solutions built for specific organizational needs. Includes internal document management, automated form filling, and error detection. Sales team engagement required for custom pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Per seat | Monthly | Nyquist Pharma - Global Pharma Data Platform |
| Per seat | Monthly | Nyquist MedTech - Global Medical Device Data Platform |
| Per seat | Monthly | All Access - Combined Pharma and MedTech |
| Per seat | Monthly | Nyquist Scholar - Systematic Literature Review Platform |
| Per seat | Monthly | Nyquist IQ - Private AI Research Ally |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
NyquistAI product offering
Product offeringCore offering
NyquistAI sells a unified AI-powered life sciences intelligence platform that consolidates decades of global clinical and regulatory documentation into searchable, context-aware insights. Its commercial products include Nyquist Pharma (global pharmaceutical pipeline and on-market therapy data), Nyquist MedTech (global medical device regulatory and clinical data), Nyquist IQ (generative AI research assistant), Nyquist Scholar (systematic literature review automation), an MCP Server delivering FDA medical device intelligence to ChatGPT and Claude, and Custom Solutions for bespoke enterprise AI builds. Customers subscribe per seat on monthly or annual terms, with publicly disclosed plans ranging from $49 to $459 per user per month.
Product overview
NyquistAI is an AI-powered life sciences intelligence company offering a unified platform with multiple integrated products. The core Global Data Platform provides AI that understands context, uncovers unsearchable insights, and delivers global results. The product portfolio includes Nyquist Pharma (global pharmaceutical data), Nyquist MedTech (global medical device data), Nyquist IQ (generative AI for data analysis and summarization), Nyquist Scholar (systematic literature review automation), NyquistAI MCP Server (integration with ChatGPT and Claude), and Custom Solutions (bespoke AI builds). All products are built on a foundation of over 1 billion Life Sciences data points and share AI capabilities for natural language processing, knowledge retrieval, and process automation.
Differentiator
Problem solved
Functional benefit
Brands
- Nyquist Pharma: Global pharma data platform for clinical pipeline and on-market therapy data in the world's largest markets
- Nyquist MedTech
- Nyquist IQ
- Nyquist Scholar
- Guidance IQ
- MCP Server
- Custom Solutions
Products and services
- Nyquist Pharma Global pharmaceutical data platform providing clinical pipeline and on-market therapy data across the world's largest markets including the US, Canada, EU, China, and Japan. Enables users to enhance clinical trial design, streamline global product launches, prioritize portfolios, evaluate market access, and conduct competitive landscape analysis. Targeted at pharmaceutical and biopharma companies, priced at $299 per seat per month ($239/month with annual prepayment).
- Nyquist MedTech Global medical device data platform providing comprehensive clinical, regulatory, and medical device data across key markets from the US to emerging markets like China. Includes predicate device genealogy and similar-device recommendations for 510(k) research, clinical trials, FDA approvals, MAUDE adverse events, recall tracking, and global manufacturing data. Targeted at medical device and MedTech companies, priced at $349 per seat per month ($279/month with annual prepayment).
- Nyquist IQ Generative AI research platform that automates data analysis, synthesis, and summarization tasks. Acts as a private and secure research ally, leveraging fine-tuned Life Sciences AI for swift insights from selected content including research papers, reports, and meetings. Enables queries across entire libraries, folders, or individual documents with curated AI training set, instant query results, transparent references, and isolated data handling. Targeted at individual researchers and small teams, priced at $49 per seat per month.
- Nyquist Scholar AI-enabled systematic literature review (SLR) platform that streamlines SLR completion times by 40-60% on screening. Features include AI-assisted paper screening with predictive scoring (Nyquist Score), automated mass exclusion, Q&A with full text articles, AI-powered PRISMA flow diagram generation, paper management, and extraction and reporting tools. Targeted at academic researchers, evidence synthesis teams, and medical affairs groups conducting SLRs, priced at $299 per seat per month ($239/month with annual prepayment).
- NyquistAI MCP Server Model Context Protocol (MCP) server that connects ChatGPT, Claude, and custom MCP clients to live FDA medical device intelligence with citations. Provides read-only access to FDA approvals (510(k), De Novo, PMA, HDE), device indications and classifications, MAUDE adverse events, recalls, establishment registrations, global clinical trials, and FDA guidance documents. Includes 10 MCP tools (usfda_company_search, usfda_device_search, usfda_guidance_search, usfda_maude_search, usfda_recall_search, global_trial_search, usfda_registration_search, usfda_inspection_citation_search, usfda_regulation_search, usfda_warning_letter_search) with OAuth 2.0 authentication and TLS 1.2+ encryption. Distributed via the ChatGPT app directory and Claude's Custom Connectors. Targeted at enterprise users wanting FDA intelligence inside their existing AI assistants.
- NyquistAI Custom Solutions Custom AI solutions built using NyquistAI's proprietary AI to integrate seamlessly with enterprise organizations. Includes internal document management, automated form filling, error detection, and bespoke AI workflows. Offers bespoke design, seamless integration with existing systems, and enhanced data security and privacy with isolated data handling. Targeted at large life sciences enterprises with unique internal workflows; pricing is custom and requires direct sales engagement.
Quantifiable outcome
- Reduces FDA MAUDE database analysis from 2.5 days to 40 minutes
- +6 more outcomes
Companies that use NyquistAI
Customer profileNamed customers16 records
Segments5 records
Ideal customer profiles4 records
NyquistAI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability9 records
Feature7 records
NyquistAI partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Google CloudcoreCloud infrastructure provider for hosting NyquistAI platform and data storage. Google Cloud provides servers following US-Swiss Safe Harbor, Privacy Shield, and ISO27001 certifications.
- Amazon Web Services (AWS)coreCloud infrastructure provider for hosting NyquistAI platform and data storage. AWS provides servers following US-Swiss Safe Harbor, Privacy Shield, and ISO27001 certifications.
- UCLA BiodesignminorAcademic partnership with UCLA Biodesign Programs. Listed among partners and used by UCLA in life sciences innovation research.
- Acquis Consulting GroupminorConsulting partner providing regulatory and quality services. Listed as a trusted partner in the NyquistAI ecosystem.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
NyquistAI competitors and assessment
Company assessmentDirect peers
- Citeline (formerly Pharma Intelligence / Informa): Citeline offers global pharmaceutical intelligence products such as TrialTrove, Pharmaprojects, and Pipeline/Medtrack, providing clinical pipeline, drug approval, and trial intelligence across major markets. It directly competes with Nyquist Pharma on drug pipeline and clinical trial data analytics.
- Advarra: Advarra provides clinical research and regulatory technology including IRB review, IBC review, and research compliance software. Its regulatory and clinical research technology stack overlaps with NyquistAI's regulatory intelligence and clinical workflow tooling for life sciences organizations.
- Clarivate: Clarivate is a large life sciences and IP intelligence company offering regulatory, clinical trial, and competitive intelligence platforms (e.g., Cortellis, Derwent). It is the closest direct competitor in pharma/medtech regulatory data and is even listed as a NyquistAI partner, making overlap in pharma intelligence particularly direct.
- PharmaCircle: PharmaCircle is a specialized pharma intelligence platform offering drug pipeline, approval, and commercial data across global markets. Its product overlaps directly with Nyquist Pharma for clinical pipeline and on-market therapy data intelligence.
- DistillerSR (by Evidence Partners): DistillerSR is a leading AI-enabled systematic literature review platform used by pharma, medtech, and academic researchers. It directly competes with Nyquist Scholar for the same SLR automation workflows, including PRISMA-compliant screening and extraction.
Emerging players
- Covidence: Covidence is a widely used systematic review management platform for academic and healthcare researchers. It is a relevant competitor to Nyquist Scholar for the academic SLR persona, though less feature-rich in AI than Nyquist Scholar.
- Trial Library: Trial Library is an emerging AI-powered clinical trial intelligence platform focused on trial feasibility and sponsor-CRO matching. It competes with NyquistAI's clinical trial and pipeline intelligence offerings, particularly for pharma sponsor use cases.
- Vivpro Corp: Vivpro is an emerging AI-powered regulatory and clinical intelligence platform for life sciences, with similar positioning around AI-augmented regulatory search and analysis. It is a comparable emerging player targeting pharma regulatory teams.
Broad incumbents
- Veeva Systems: Veeva is the dominant cloud software provider for life sciences, including Vault RIM for regulatory information management. While broader than NyquistAI, Veeva overlaps on regulatory document management and submission intelligence for pharma customers.
- IQVIA: IQVIA is the largest life sciences technology and clinical research services company globally, spanning clinical trial data, real-world evidence, and commercial analytics. Its breadth of proprietary clinical and regulatory data positions it as a broad incumbent competitor to NyquistAI's pharma intelligence platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
NyquistAI social profiles
Digital presenceNyquistAI compliance and trust
Trust signalCompliance3 records
NyquistAI financial estimates
Financial estimateRevenue estimate
Valuation estimate
NyquistAI leadership team
Management profileNumber of profiles
Profiles2 records
NyquistAI funding detail
Funding detailFunding overview
Funding rounds3 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NyquistAI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NyquistAI
What does NyquistAI do?
NyquistAI sells a unified AI-powered life sciences intelligence platform that consolidates decades of global clinical and regulatory documentation into searchable, context-aware insights. Its commercial products include Nyquist Pharma (global pharmaceutical pipeline and on-market therapy data), Nyquist MedTech (global medical device regulatory and clinical data), Nyquist IQ (generative AI research assistant), Nyquist Scholar (systematic literature review automation), an MCP Server delivering FDA medical device intelligence to ChatGPT and Claude, and Custom Solutions for bespoke enterprise AI builds. Customers subscribe per seat on monthly or annual terms, with publicly disclosed plans ranging from $49 to $459 per user per month.
Is NyquistAI a public or private company?
NyquistAI is a private company. It is classified as venture growth investor backed and is currently operating.
When was NyquistAI founded?
NyquistAI was founded in 2020. It employs 11 to 50 people.
Where is NyquistAI based?
NyquistAI is headquartered in Palo Alto, United States, in the North America region.
How does NyquistAI make money?
Four revenue lines are on record. Subscription SaaS - Global Intelligence Plans are the primary driver. The others are subscription SaaS - Nyquist Scholar, subscription SaaS - Nyquist IQ and custom Solutions.
Who are NyquistAI's main competitors?
Direct peers on record are Citeline (formerly Pharma Intelligence / Informa), Advarra, Clarivate, PharmaCircle and DistillerSR (by Evidence Partners). Emerging players are Covidence, Trial Library and Vivpro Corp. Broad incumbents are Veeva Systems and IQVIA.
Does NyquistAI have an API?
Yes. NyquistAI MCP Server provides a remote Model Context Protocol server that connects ChatGPT, Claude, and custom MCP clients to live FDA medical device intelligence with citations. The server is read-only and provides access to approvals, clearances, recalls, adverse events, guidance, and clinical trials. It uses OAuth 2.0 for authentication and TLS 1.2+ encryption. The MCP Server URL is https://mcp.nyquistai.com/agent/mcp. Available tools include: usfda_company_search (find applicant companies with FDA-approved devices), usfda_device_search (search FDA-cleared and approved devices), usfda_guidance_search (search FDA guidance), usfda_maude_search (surface adverse events in MAUDE), usfda_recall_search (track FDA device recalls), global_trial_search (search global clinical trials), usfda_registration_search (search FDA establishment registrations), usfda_inspection_citation_search (search FDA inspection citations), usfda_regulation_search (search CFR Title 21), and usfda_warning_letter_search (search FDA warning letters). Developer documentation is at www.nyquistai.com/mcp-doc.
What industry is NyquistAI in?
NyquistAI's product category is Life Sciences Regulatory Intelligence Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 5132 and its SIC code is 7372.